‘Superpotent’ thyroid medication recalled one month after FDA advises against similar tablets

Fonte: New York Post

Originally Published by: Retirement plans may be sharing or selling Americans' personal data Target pulls 'offensive' Halloween costume critics accused of evoking blackface US-Canada trade negotiations suspended Vitruvias Therapeutics is recalling one lot of thyroid medication distributed nationwide after testing found the tablets could be more potent than intended, according to a recall notice published by the U. S. Food and Drug Administration (FDA).